Thank you very much, Madam Chair.
I want to thank Ms. Yeates for clearing up the misinformation that's out there on blood products.
I want to take this opportunity as well to congratulate Mr. Roberge. I know about all the work you've done over the years, and your retirement is certainly well earned. Thank you very much for all the work you've done for Canadians.
I wanted to ask a question about SPOR, because at the end of the day, it's about the Canadian patient. I realize that Health Canada is taking a significant leadership role. In committee this week, we heard from somebody from Oshawa, Dr. Carolyn McGregor, who mentioned the work being done through the strategy for patient-oriented research, SPOR, and the benefit it provides to the Canadian health care system. I was wondering if you could discuss SPOR in budget 2013 and any proposed funding that is going to be allocated to SPOR, because we're hearing some great feedback on that.